Images de page
PDF
ePub

standards to the environmental analytical comarunity at reasonable cost while reducing the impact of doing so on ilmited appropriated funds.

We appreciate the Interest of you and your constituent in this matter.

[blocks in formation]
[merged small][ocr errors][graphic]

National Institutes of Health
Alcohol, Drug Abuse, and Mental Health Administration

October 1989

[blocks in formation]

ACKNOWLEDGEMENTS

The Directory is sponsored by the National Institutes of Health (NIH) and the Alcohol, Drug Abuse and
Mental Health Administration (ADAMHA).
NIH/ADAMHA Patent Policy Board

Dr. Philip S. Chen, Jr., NIH, OD; Chairman
Ms. Kathleen M. Conn, NIH, OD; Executive Secretary
Mr. Reid G. Adler, NIH, OD
Dr. Richard H. Adamson, NCI
Dr. John H. Ferguson, NIH, OD
Dr. Peter L. Frommer, NIH, NHLBI
Dr. George J. Galasso, NIH, OD
Dr. John I. Gallin, NIH, NIAID
Mr. John D. Mahoney, NIH, OD
Mr. Edward H. McManus, NIH, NEI
Dr. Jay Moskowitz, NIH, OD
Dr. Lana R. Skirboll, ADAMHA, OA
Mr. J. Emmett Ward, NIH, DCRT
Dr. Richard G. Wyatt, NIH, OD

Forum Planning Committee

Dr. George J. Galasso, NIH, OD; Chairman
Dr. Philip S. Chen, Jr., NIH, OD
Ms. Kathleen M. Conn, NIH, OD
Ms. Carolyn Craig, NIH, OD
Ms. Sue Ohata, NIH, OD

This Directory is produced in conjunction with the annual NIHADAMHA-Industry Collaboration Forum. The Forum Planning Committee expresses its appreciation to Dr. Cyrus Creveling and Dr. Charles Roberts from the National Institute of Diabetes and Digestive and Kidney Diseases for their valuable help in developing the keyword lists.

INTRODUCTION

The Federal Technology Transfer Act of 1986 has provided new incentives for both Federal scientists and industrial companies to participate in Cooperative Research and Development Agreements (CRADAs), and thus facilitate the transfer of technology from the Federal laboratory into public use by product commercialization. Industrial companies can now obtain an exclusive license to use patented inventions developed under a CRADA, particularly in view of the resources contributed to the CRADA by the company. The NIH/ADAMHA-Industry Collaboration Forum provides a means for industrial representatives and Federal scientists to contact one another and identify areas of mutual collaborative interest which might result in a CRADA.

This directory contains lists of keywords identifying the areas of interest of participating government scientists and industrial representatives, address lists of participating NIH/ADAMHA scientists and industrial representatives, and information regarding NIH/ADAMHA resource personnel, including the Technology Development Coordinators for each Bureau, Institute, or Division (BID) within NIH and ADAMHA Section 1: List of acronyms of participating DHHS agencies, institutes, and divisions. Section 2: An alphabetical list of keywords and names of all NIH, ADAMHA, and FDA scientists who

have indicated this keyword as an area of collaboration interest Section 3: List of addresses of all participating Federal scientists. Section 4: An alphabetical list of keywords and names of all companies that have indicated this

keyword as an area of collaboration interest. Section 5: List of addresses of all participating companies and their company representatives. Section 6: List of resource personnel who can address questions regarding NIH and ADAMHA policy

and procedures in the implementation of the Federal Technology Transfer Act of 1986. This listing includes: staff members of the NIH Office of Invention Development; the Technology Development Coordinators (TDCs) from each institute; the Department of Health and Human Services Patent Branch attorneys; the NIH and ADAMHA Legal Advisors, and representatives from the Department of Commerce National Technical Information Service

(NTIS) Section 7: List of existing Cooperative Research and Development Agreements (CRADAS). Section 8: NIH/ADAMHA policy statement, and model CRADA and MTA. Section 9: List of existing DHHS-owned patents available through NTIS for licensing to interested

companies

« PrécédentContinuer »